Normax estimates that the average cost for Normax Vax Factory to manufacture mRNA Vaccines at large scale for infectious diseases is about $2.00 per dose, or less.
Normax plans to sell our mRNA Vaccines for infectious diseases on large scale advance purchase agreements (APA) with customers at about $4.00 per dose.
This represents a gross profit on sales of 100%.
While big pharma charges anywhere from $8 to $35 per COVID vaccine dose, Normax believes that a 100% gross profit mark-up on sales represents a sustainable and profitable high-impact business for our investors.
The first mRNA Vaccines currently in early stage research and development by Normax are for:
- SARS-CoV-2 with a “Universal Covid Vaccine” (UCV)
- Tuberculosis (TB)
- Human Immunodeficiency Virus (HIV)
- Malaria
In theory, mRNA vaccines by Normax could save-a-life for less than the cost of a hamburger.